TransEnterix won expanded indications from the FDA for its Senhance robot-assisted surgical system. In the U.S., Senhance is now cleared for laparoscopic colorectal, gynecologic, inguinal hernia and cholecystectomy surgery.
This is a companion discussion for the article “TransEnterix Senhance surgical robot gets approved for new procedures - https://www.therobotreport.com/transenterix-senhance-approved-procedures/” submitted on the community's news feed.
Reply to this topic to share your thoughts on this article.